rs138967272
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000399.5(EGR2):c.1352G>T(p.Gly451Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000591 in 1,572,584 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G451D) has been classified as Likely benign.
Frequency
Consequence
NM_000399.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EGR2 | NM_000399.5 | c.1352G>T | p.Gly451Val | missense_variant | 2/2 | ENST00000242480.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EGR2 | ENST00000242480.4 | c.1352G>T | p.Gly451Val | missense_variant | 2/2 | 1 | NM_000399.5 | A1 |
Frequencies
GnomAD3 genomes ? AF: 0.000335 AC: 51AN: 152238Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00107 AC: 234AN: 218404Hom.: 3 AF XY: 0.00145 AC XY: 167AN XY: 115490
GnomAD4 exome AF: 0.000619 AC: 879AN: 1420228Hom.: 16 Cov.: 31 AF XY: 0.000873 AC XY: 612AN XY: 700836
GnomAD4 genome ? AF: 0.000328 AC: 50AN: 152356Hom.: 0 Cov.: 32 AF XY: 0.000483 AC XY: 36AN XY: 74510
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 1D Uncertain:1Benign:2
Uncertain significance, no assertion criteria provided | literature only | Inherited Neuropathy Consortium Ii, University Of Miami | Jan 06, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Charcot-Marie-Tooth disease Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Molecular Genetics Laboratory, London Health Sciences Centre | - | - - |
Uncertain significance, no assertion criteria provided | literature only | Inherited Neuropathy Consortium | - | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2022 | EGR2: BP4, BS1 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 11, 2021 | This variant is associated with the following publications: (PMID: 28902413, 11545686, 22765307) - |
Charcot-Marie-Tooth disease, type I Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Nov 15, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at